Frank Jankowitsch

Title: Innovations of Frank Jankowitsch in Biochemical Production

Introduction

Frank Jankowitsch is a notable inventor based in Sassenberg, Germany. He has made significant contributions to the field of biochemical production, particularly in the fermentative production of amino acids and related compounds. With a total of three patents to his name, Jankowitsch's work has implications for various industrial applications.

Latest Patents

One of Jankowitsch's latest patents is a method for the fermentative production of L-lysine using strains that express modified gluconate repressor proteins GntR1 and GntR2. These modified strains demonstrate an increased ability to produce L-lysine compared to wild-type strains. The gluconate repressor protein GntR1 features an amino acid sequence where the amino acid Arg at position 102 is replaced by Glu. Additionally, the gluconate repressor protein GntR2 has an attenuated activity compared to its wild-type counterpart. Another significant patent involves a method for the fermentative production of guanidinoacetic acid (GAA), where a microorganism is transformed to produce GAA. This method can also be applied to the fermentative production of creatine.

Career Highlights

Frank Jankowitsch is currently associated with Evonik Operations GmbH, where he continues to innovate in the field of biochemical production. His work has been instrumental in advancing methods that enhance the efficiency of producing valuable compounds through fermentation processes.

Collaborations

Jankowitsch collaborates with notable colleagues such as Frank Schneider and Silke Jerrentrup, contributing to a dynamic research environment that fosters innovation and development in biochemical technologies.

Conclusion

Frank Jankowitsch's contributions to the field of biochemical production through his innovative patents highlight his role as a key inventor in this area. His work not only advances scientific understanding but also has practical applications in various industries.